Evidence map›Paper›PMID 33544460›Full record

ArticleJournal of cellular and molecular medicine2021

Deubiquitylation and stabilization of ARMC5 by ubiquitin-specific processing protease 7 (USP7) are critical for RCC proliferation.

Guobei Yan, Na Liu, Jun Tian, Yanli Fu, Wei Wei, Jingjing Zou, Suping Li, Qing Wang, Kai Li, Junhua Wang

Open access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. USP7 accelerates FMR1-mediated ferroptosis by facilitating TBK1 ubiquitination and DNMT1 deubiquitination after renal ischemia-reperfusion injury.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2022
    Article
  11. Adrenocortical carcinoma: Pediatric aspects (Review).Experimental and therapeutic medicine · 2022
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Guobei YanDepartment of Laboratory, The Second People's Hospital of Jiaozuo, the First Affiliated Hospital of Henan Polytechnic University, Jiaozuo, China.ORCID 0000-0001-8022-4001
Na LiuHenan Polytechnic University, Jiaozuo, China.
Jun TianDepartment of Laboratory, Jiaozuo Maternal and Children's Hospital, Jiaozuo, China.
Yanli FuDepartment of Laboratory, The Second People's Hospital of Jiaozuo, the First Affiliated Hospital of Henan Polytechnic University, Jiaozuo, China.
Wei WeiDepartment of Laboratory, The Second People's Hospital of Jiaozuo, the First Affiliated Hospital of Henan Polytechnic University, Jiaozuo, China.
Jingjing ZouDepartment of Laboratory, The Second People's Hospital of Jiaozuo, the First Affiliated Hospital of Henan Polytechnic University, Jiaozuo, China.
Suping LiDepartment of Laboratory, The Second People's Hospital of Jiaozuo, the First Affiliated Hospital of Henan Polytechnic University, Jiaozuo, China.
Qing WangDepartment of Laboratory, The Second People's Hospital of Jiaozuo, the First Affiliated Hospital of Henan Polytechnic University, Jiaozuo, China.
Kai LiDepartment of Laboratory, The Second People's Hospital of Jiaozuo, the First Affiliated Hospital of Henan Polytechnic University, Jiaozuo, China.
Junhua WangHenan Polytechnic University, Jiaozuo, China.
Henan Polytechnic University · CNJiaozuo University · CN

Funding

Key Research plan of Higher education of Henan Province 19A310010National Natural Science Foundation of China NSFC81671807The project of Henan Polytechnic University Q2018-5
6 · The paper itself

Abstract

The ubiquitin-proteasome system is an essential regulator of ARMC5, which serves as a new tumour suppressor protein for inhibiting meningiomas and hereditary adrenocortical tumorigenesis. However, the precise mechanism for the deubiquitination of ARMC5 is still not fully understood. A Western blot analysis of ARMC5 was performed and showed that the expression of ARMC5 was decreased in the renal cancer cell tissues and lines. By screening a deubiquitinase library, we identified USP7 as a potential ARMC5 associated deubiquitinase. In this paper, we demonstrated that there was an interaction between USP7 and ARMC5 in vivo and in vitro. Employing the overexpression and knockdown assay indicated that USP7 could greatly increase the steady state of ARMC5 through the ubiquitin-proteasome pathway and regulate ARMC5 ubiquitination. Moreover, USP7 altered cell cycle G1/S phases and regulated renal cancer cell proliferation by targeting ARMC5. Together, these results suggest that USP7 plays an important role in the RCC proliferation through modulating ARMC5 stability.

Indexed as

Armadillo Domain ProteinsCarcinoma, Renal CellCell CycleCell Line, TumorCell ProliferationGene ExpressionHumansKidney NeoplasmsUbiquitinationUbiquitin-Specific Peptidase 7Armadillo Domain ProteinsARMC5 protein, humanUbiquitin-Specific Peptidase 7USP7 protein, humanARMC5proliferationrenal cell carcinomaUSP7

Identifiers

PMID33544460
PMCPMC7957176
OpenAlexW3126359783

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.